Revolutionizing discarded resources into premium wellness materials
Developing patented collagen, PDRN, and advanced biotics for global markets
Committed to environmental harmony and human well-being
Expanding product lines across cosmetics, nutraceuticals, and medical foods

ShinSung BioPharm, a future-oriented biotech innovator based in Gangneung, South Korea, is redefining sustainability in the beauty and health industries. Using its proprietary SST (Shin Sung Technology) method, the company transforms discarded salmon byproducts—an often-overlooked environmental challenge—into high value-added raw materials and finished products.

By extracting T1 collagen, a bioactive substance that supports skin elasticity and joint health, and PDRN (Polydeoxyribonucleotide), a DNA-derived compound known for its skin regeneration properties, ShinSung BioPharm addresses both ecological concerns and consumer wellness demands. The company also produces a range of pre-, pro-, para-, and postbiotics using its own culture technology, enhancing gut health and immune support.

Its flagship raw materials include:

Nanocollagen SSB – Patented nanosized T1 collagen (231 Da) for superior bioavailability.

Salmon PDRN SSB – Regeneration-boosting extract from salmon DNA.

SSB Biotics – Comprehensive biotic formulations, complemented by Beta Glucan and low-molecular hyaluronic acid.

With applications spanning cosmetics, pharmaceuticals, and functional foods, ShinSung BioPharm is actively developing innovative products in inner beauty, topical skincare, and medi-foods. These advancements position the company as a strategic partner for global brands seeking sustainable, science-backed ingredients.

“Our mission is to merge environmental stewardship with human well-being,” said CEO Mira Song. “By upcycling salmon byproducts into premium health solutions, we’re proving that innovation can protect our planet while improving lives.”

ShinSung BioPharm is currently seeking strategic partnerships and investment opportunities totaling approximately USD 2.2 million to accelerate global expansion and product commercialization.

About ShinSung BioPharm

Founded in Gangneung, South Korea, ShinSung BioPharm specializes in sustainable bio-material innovation. Leveraging its proprietary SST technology, the company transforms discarded salmon byproducts into high-performance raw materials, delivering solutions for beauty, health, and environmental preservation. For more information, visit www.shinsunglab.co.kr.